Abstract
Left ventricular assist devices (LVADs) have been increasingly used in patients with advanced heart failure, either as a destination therapy or as a bridge to heart transplant. Continuous flow (CF) LVADs have revolutionized advanced heart failure treatment. However, significant vascular pathology and complications have been linked to their use. While the newer CF-LVAD generations have led to a reduction in some vascular complications such as stroke, no major improvement was noticed in the rate of other vascular complications such as gastrointestinal bleeding. This review attempts to provide a comprehensive summary of the effects of CF-LVAD on vasculature, including pathophysiology, clinical implications, and future directions.
| Original language | English |
|---|---|
| Article number | 757 |
| Journal | Biomedicines |
| Volume | 11 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1 Mar 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- continuous flow left ventricular assist device
- coronary artery disease
- gastrointestinal bleeding
- peripheral artery disease
- pulmonary hypertension
- stroke
ASJC Scopus subject areas
- Medicine (miscellaneous)
- General Biochemistry, Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Vascular Function in Continuous Flow LVADs: Implications for Clinical Practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver